or inflammation associated with the gradual degeneration of the cartilage-bearing surfaces (arthritis)
GHK-Cu avoids systemic hormone disruption, making it safer for a broader range of individuals, including women
It can also make food shifts and gut therapies work better
For women with chronic digestive disorders that disrupt nutrition or increase systemic inflammation, BPC-157 may be included in an approach to optimize the metabolic and immune landscape for conception and early pregnancy
Melittin, a major peptide component of bee venom, and its conjugates in cancer therapy
Foundayo (orforglipron), developed by Eli Lilly, is a new, once-daily oral GLP-1 weight-loss pill approved in the UAE (second globally after the US) and expected to be available from May 2026